|
May 23
|
New Tests Promise to Reveal the Secrets in Your Blood
|
|
May 22
|
Guardant Health and Collaborators to Present Over 19 Studies Demonstrating Role of Liquid Biopsy in Advancing Precision Oncology at 2025 ASCO Annual Meeting
|
|
May 21
|
Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know
|
|
May 21
|
Guardant Health (GH) introduces IHC Solid Tumor Testing to its Portfolio
|
|
May 21
|
Guardant Health Introduces Comprehensive Immunohistochemistry Testing for Solid Tumors
|
|
May 20
|
Guardant Health Introduces Hereditary Cancer Testing to Identify Inherited Predispositions to Certain Types of Cancer
|
|
Apr 17
|
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
|
|
Apr 15
|
Guardant Health price target raised to $60 from $56 at BofA
|
|
Apr 3
|
Guardant Health and Bayshore HealthCare Partner to Expand Access to Advanced Precision Oncology Testing in Canada
|
|
Apr 1
|
3 Small-Cap Stocks in the Doghouse
|
|
Apr 1
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|
|
Mar 25
|
Guardant Health’s Shield Blood Test Now Covered for VA Community Care Beneficiaries
|
|
Mar 11
|
Guardant Health Receives ADLT Status From CMS for Shield Blood Test
|
|
Feb 24
|
Guardant accuses Natera of poaching employees, stealing trade secrets
|
|
Feb 22
|
Guardant Health price target raised to $56 from $42 at TD Cowen
|
|
Feb 22
|
Guardant Health Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Feb 21
|
These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50
|
|
Feb 21
|
What's Going On With Cancer Diagnostic Firm Guardant Health On Friday?
|
|
Feb 21
|
Guardant Health Inc (GH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
|
|
Feb 20
|
Guardant Health (GH) Reports Q4 Earnings: What Key Metrics Have to Say
|